Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Teresa L Kauf, Keith L Davis, Stephanie R Earnshaw & E Anne Davis. (2012) Spillover adherence effects of fixed-dose combination HIV therapy. Patient Preference and Adherence 6, pages 155-164.
Read now
Read now
Anita J. Brogan, Joseph Mrus, Andrew Hill, Anthony W. Sawyer & Erik Smets. (2010) Comparative Cost-Efficacy Analysis of Darunavir/ritonavir and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in the United States. HIV Clinical Trials 11:3, pages 133-144.
Read now
Read now
Sanjeev Balu, Robert J. Simko, Ralph M. Quimbo & Mark J. Cziraky. (2009) Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence. Current Medical Research and Opinion 25:11, pages 2765-2775.
Read now
Read now
K. M. Beusterien, E. A. Davis, R. Flood, K. Howard & J. Jordan. (2008) HIV patient insight on adhering to medication: a qualitative analysis. AIDS Care 20:2, pages 244-252.
Read now
Read now
Articles from other publishers (20)
Lei Huang, Jing Lei, Yuanxun Yang, Tingting Ma, Hui Lin, Bei Cao & Juan Li. (2023) Pharmacokinetic and Bioequivalence Evaluation of Single‐Tablet and Separate‐Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects. Clinical Pharmacology in Drug Development.
Crossref
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Crossref
Isaac Nofrerias, Anna Nardi, Marc Suñé-Pou, Josep M. Suñé-Negre, Encarna García-Montoya, Pilar Pérez-Lozano, Montserrat Miñarro, Bernard Bataille & Josep R. Ticó. (2019) Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl’ONE Results. AAPS PharmSciTech 21:1.
Crossref
Crossref
Kimia Kamelian, Katherine J Lepik, William Chau, Benita Yip, Wendy W Zhang, Viviane Dias Lima, Marjorie A Robbins, Conan Woods, Andrea Olmstead, Jeffrey B Joy, Rolando Barrios & P Richard Harrigan. (2019) Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis. Open Forum Infectious Diseases 6:3.
Crossref
Crossref
S. Scott Sutton, Joseph Magagnoli & James W. Hardin. (2017) Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:2, pages 204-213.
Crossref
Crossref
S. Scott Sutton, Divya Ahuja & Joseph Magagnoli. (2016) What is the effect of pill burden on adherence to HIV antiretroviral therapy?. JAAPA 29:11, pages 16-17.
Crossref
Crossref
A Rotzinger, I Locatelli, O Bugnon, A Fayet Mello, J-J Parienti, M Cavassini & M.P Schneider. (2016) Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients’ perceptions and drug management. HIV Medicine 17:5, pages 390-396.
Crossref
Crossref
S. Scott Sutton, Joseph Magagnoli & James W. Hardin. (2016) Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:4, pages 385-401.
Crossref
Crossref
Anita J. Brogan, Erik Smets, Josephine A. Mauskopf, Sarah A. L. Manuel & Ines Adriaenssen. (2014) Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada. PharmacoEconomics 32:9, pages 903-917.
Crossref
Crossref
Rubeena Ramjan, Alexandra Calmy, Marco Vitoria, Edward J. Mills, Andrew Hill, Graham Cooke & Nathan Ford. (2014) Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy. Tropical Medicine & International Health 19:5, pages 501-513.
Crossref
Crossref
Erik Smets, Anita J. Brogan, Andrew Hill, Ines Adriaenssen, Anthony W. Sawyer, Pere Domingo-Pedrol, Joana Gostkorzewicz & Francisco Ledesma. (2013) Análisis comparativo de coste-eficacia entre darunavir/ritonavir y otros inhibidores de la proteasa en el tratamiento de la infección por el virus de la inmunodeficiencia humana de tipo 1 en pacientes naïve en España. Enfermedades Infecciosas y Microbiología Clínica 31:7, pages 430-436.
Crossref
Crossref
Paul E. Sax, Juliana L. Meyers, Michael Mugavero & Keith L. Davis. (2012) Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States. PLoS ONE 7:2, pages e31591.
Crossref
Crossref
Joshua S. Benner, Richard H. Chapman, Allison A. Petrilla, Simon S. K. Tang, Noah Rosenberg & J. Sanford Schwartz. (2009) Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. American Journal of Health-System Pharmacy 66:16, pages 1471-1477.
Crossref
Crossref
Shuchita Agarwal, Simon S K Tang, Noah Rosenberg, Dan Pettitt, Trent McLaughlin, Amie Joyce & J Sanford Schwartz. (2009) Does Synchronizing Initiation of Therapy Affect Adherence to Concomitant Use of Antihypertensive and Lipid-Lowering Therapy?. American Journal of Therapeutics 16:2, pages 119-126.
Crossref
Crossref
J. F. Marier, M. DiMarco, R. Guilbaud, C. Dodard, G. Morelli, S. K. Tippabhotla, A. K. Singla, N. R. Thudi & T. Monif. (2007) Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed-Dose Combination Formulation Versus Coadministration of the Individual Products. The Journal of Clinical Pharmacology 47:11, pages 1381-1389.
Crossref
Crossref
R. Hansen, R. Seifeldin & L. Noe. (2007) Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression. Transplantation Proceedings 39:5, pages 1287-1300.
Crossref
Crossref
Phebe K. Lam, Sylvie Naar-KingKathryn Wright. (2007) Social Support and Disclosure as Predictors of Mental Health in HIV-Positive Youth. AIDS Patient Care and STDs 21:1, pages 20-29.
Crossref
Crossref
Karina M Berg & Julia H Arnsten. (2006) Practical and Conceptual Challenges in Measuring Antiretroviral Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 43:Supplement 1, pages S79-S87.
Crossref
Crossref
. (2006) Erratum. JAIDS Journal of Acquired Immune Deficiency Syndromes 41:3, pages 396.
Crossref
Crossref
Nestor Sosa, Christina Hill-Zabala, Edwin DeJesus, Gisella Herrera, Allison Florance, Maria Watson, Cindy Vavro & Mark Shaefer. (2005) Abacavir and Lamivudine Fixed-Dose Combination Tablet Once Daily Compared With Abacavir and Lamivudine Twice Daily in HIV-Infected Patients Over 48 Weeks (ESS30008, SEAL). JAIDS Journal of Acquired Immune Deficiency Syndromes 40:4, pages 422-427.
Crossref
Crossref
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})